Digoxin Injection 250 mcg/mL Suppliers & Bulk Manufacturers
Available Forms: Intravenous (IV) Injection
Available Strengths: 250 mcg/mL
Reference Brands: Lanoxin(US & EU)
Category: Critical Care
Digoxin is a key cardiac drug for heart failure and atrial fibrillation, available as oral tablets, oral solution, and 250 mcg/mL IV injection. Brands include Lanoxin and Digoxin Hameln. It is widely supplied to hospitals and clinics via pharma B2B procurement networks and institutional cardiac care supply chains.
Product Description:
Digoxin is a cardiac glycoside used in the treatment of heart failure and atrial fibrillation. It enhances myocardial contractility while controlling ventricular rate by inhibiting the sodium-potassium ATPase pump. Available in oral tablets (62.5, 125, and 250 mcg), oral solution (50 mcg/mL), and IV injection (250 mcg/mL), Digoxin is widely used in both acute and chronic cardiac care. In the US, Lanoxin and Pfizer’s generic injections are common, while EU brands include Lanoxin, Digoxin Hameln, and Meda. Hospitals, cardiology centers, and clinics procure Digoxin regularly through pharma B2B platforms and hospital group purchasing organizations.
Digoxin Injection — third party manufacturing & bulk supply
Digoxin Injection 250 mcg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Digoxin Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Digoxin Injection →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Digoxin Injection contains Digoxin, a cardiac glycoside derived from the Digitalis plant. It works by inhibiting the sodium-potassium ATPase pump in heart cells, increasing intracellular calcium, which strengthens heart contractions and slows the heart rate.
Trade names include Lanoxin Injection and various generic formulations available globally.
Digoxin Injection is manufactured by multiple pharmaceutical companies, including Pfizer, Cipla, and Sun Pharma.
The generic name is Digoxin.
Brand names include Lanoxin Injection, Digoxin Injection (Cipla, Sun Pharma, Lupin), and other regional generics.
Digoxin Injection is manufactured in the USA, Europe, India, and other regions by multiple approved pharmaceutical companies under regulatory standards.
Related Products
Ringer's Lactate
Strength:
100 mL, 250 mL, 500 mL, 1000ml
Form: Infusion
Reference Brands: Generic formulations marketed under different names
View Details
Rolapitant Hydrochlorid
Strength:
90 mg
Form: Tablets
Reference Brands: Varubi(USA/LATAM), Varuby(EU)
View Details
Conivaptan Hydrochloride
Strength:
20 mg/100 mL
Form: Infusion
Reference Brands: Vaprisol (USA)
View Details
Fitusiran
Strength:
50 mg/0.5 ml, 20 mg/0.2ml
Form: injection (prefilled syringe)
Reference Brands: Generic formulations marketed under different names
View DetailsQuick Response Guaranteed | Verified Suppliers
